Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01302 LIFETECH SCI
RTNominal down1.590 -0.030 (-1.852%)
Others

21/07/2021 17:48

LifeTech Sci (01302) sees 100-110% increase in interim net

[ET Net News Agency, 21 July 2021] LifeTech Scientific Corporation (01302) said for the
six months ended 30 June 2021, the group is expected to record no less than RMB200 million
in profit attributable to owners of the company, representing an increase ranging from
100% to 110% as compared to the corresponding period in 2020.
Such significant increase was primarily attributable to (i) an increase in the sales
revenue and gross profit from each business segment of the group, its overall gross profit
recorded an increase ranging from 70% to 75% as compared to the corresponding period in
2020; and (ii) the investment income generated from Ally Bridge Group Innovation Capital
Partners III, L.P. was approximately RMB27.7 million for the six months ended 30 June
2021, representing an increase of approximately RMB17.7 million as compared to the
corresponding period in 2020. (RC)

Remark: Real time quote last updated: 19/04/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.